欧州のAI支援医療画像市場：2025年

レポートのメタデータ

• 地理的範囲欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州全域）
• モダリティCT、MRI、X線/DR、超音波、PET/核医学
• 臨床分野腫瘍学、神経学/脳卒中、心臓病学、呼吸器/肺、MSK/整形、一般診断
• 用途：早期発見/トリアージ、診断精度と分類、ワークフロー/効率、予後と治療、画像強調/線量、セグメンテーション/特徴抽出、モダリティ間の統合
• 収益の流れハードウェア（工場出荷時のCAPEXアップリフト）、ソフトウェア（企業向けサブスクリプションを含む固定ライセンス）、サービス（導入／検証／サポート）、クラウド／ペイ・パー・ユース（スキャンごとの従量課金）
• 最終用途病院、画像診断センター、クリニック、テレラジオロジー、その他プロバイダー

レポートサマリー

欧州のAI支援医療画像市場：2025年レポートは、ドイツ、フランス、英国、イタリア、スペイン、その他の欧州諸国のCT、MRI、X線/DR、超音波、PET/核医学におけるAIへの支出を測定・予測しています。2023年～2024年の実績と2025年～2032年の予測を、モダリティ別、臨床分野別、用途別、収益源別、最終用途組織別、AI技術別、さらに欧州に合わせたGTM成長・成熟度、エコシステム連携、ソリューション導入・成長フレームワーク別に掲載しています。

このMarketstrat（TM）の88ページにわたるMarkintel（TM）Pulseレポートは、医療用画像処理におけるAIについて欧州のみを対象としています。地域別フレームワーク-GTM成長と成熟度（ベンダービュー）、エコシステムコラボレーションマトリックス、ソリューション採用と成長-は、エビデンスをシーケンス、提携、価格決定へと変換します。ドイツ、フランス、英国、イタリア、スペイン、その他の欧州諸国の国別の章では、GTMの準備状況、価格設定の適合性、階層化された顧客情勢を掲載しています。調査手法では、欧州のトップダウン支出モデルと、モダリティ別および国別のボトムアップ装着率×ASPエンジンを調整し、規制当局への提出書類、監査済み財務情報、ライセンス取得済み専門家の講演録、RWEによって重み付けしています。

各国の現実：ドイツは2027年までにモジュール型SaaSに軸足を移し、英国はクラウド／利用価格を重視、フランスは統合とコンプライアンスを優先、イタリアはPNRRを通じてMR主導のAIを成長、スペインのケースはバックログの削減、RoEクラスターは強力なレトロフィットの可能性を示します。

意思決定のためのフレームワークGTMの成長と成熟度、エコシステム・コラボレーション、ソリューションの採用と成長-すべて欧州レベル。

本レポートの対象者

• OEMのリーダーシップ（製品、地域GM、戦略）
• AI専門ベンダー＆プラットフォーム（創業者、セールスリーダー、パートナーシップ）
• プロバイダーネットワーク（CIO/CMIO、放射線科委員長、調達）
• 投資家および株式アナリスト（医療技術/HCIT）
• コンサルティング＆アドバイザリーファーム（GTM、プライシング、デリジェンス）

どのような意思決定をサポートするか（現在／来四半期）

• 市場でのリストに対して、エンタープライズ/プラットフォーム取引のためにどのソリューションをバンドルするか
• 国別の価格設定（期間制か企業向けサブスクリプションか利用ベースか）
• 調達ケイデンスとエビデンスの期待に連動したパイロットからスケールプラン
• 国ごとのパートナールート（OEMストア、PACSマーケットプレース、クラウドエクスチェンジ）

内容

• 欧州の主要数字：2032年までの合計と成長のマイルストーン
• モダリティ別、臨床領域別、用途別、収益源別、最終用途別、AI技術別の内訳
• 国別チャプター（ドイツ、フランス、英国、イタリア、スペイン、その他欧州全域）
• GTM準備レーダー、国別価格マトリックス、階層別顧客情勢、予測表
• 地域別フレームワーク（欧州レベル）
  • GTMの成長と成熟度- ベンダー・マップ
  • エコシステム連携マトリックス（ECM）
  • ソリューション導入＆成長マトリクス
• 調査手法：デュアルレンズモデル（トップダウン調整、ボトムアップ装着率×ASP）、エビデンス重み付け、QAチェック

このパルスレポートを購入する理由

• 1つの首尾一貫したモデル：モダリティ、国、アプリケーション、収益の流れを横断して数字を調整
• エビデンスの重み付け：規制、財務、インタビューに基づくシグナルを、明確な信頼性の重み付けと組み合わせる
• 行動志向：フレームワークがデータをシーケンス、提携、価格設定に反映
• カスタムスタディよりも迅速：欧州に焦点を絞ったスコープで、今すぐご利用いただけます。

メソッドの概要

• デュアルレンズアーキテクチャ：トップダウンの欧州の支出アンカー合計と、ボトムアップの各モダリティと国の添付文書作成率×ASPエンジンサイズ
• エビデンスの柱：CE MDR/UKCAファイリング、監査済み財務、ライセンス取得済み専門家の通話記録、ピアレビューまたはカンファレンスRWE
• QA：表/図間の数値の一致、文書化されたソーストレイル、セカンドリーダーの編集チェック

目次

セクション1-エグゼクティブサマリー

セクション2-調査手法

• このパルスレポートについて
• スコープとセグメンテーション
• Marketstratの「洞察→アクション」アプローチ
• デュアルレンズアーキテクチャ
• トップダウン型マーケットファネル（欧州）
• ボトムアップ接続率フロー（欧州）
• 各国およびセグメントごとにモデル化する内容
• 証拠の信頼性- 密度と信頼性（欧州）
• このパルスレポートに含まれる地域フレームワーク
• GTMカントリーツール
• 品質保証とガバナンス
• 制限と緩和策

セクション3-欧州市場分析

• 市場概要と分析
  • 市場スナップショット
  • 構造的な需要シグナル
  • 規制と資金調達の情勢（2024年～2028年）
  • 市場セグメンテーション：2032年（価値シェア）
  • 競争ヒートマップ（2024年～2026年）
  • 実行プレイブック（2024年～2027年）
  • 行動指向の推奨事項
• 欧州市場推計・予測（2023年～2032年、100万米ドル）
• Markintel成長成熟度マトリックス- 欧州
• Markintelエコシステムコラボレーションマトリックス（ECM）- 欧州
• Markintelソリューション導入および成長マトリックス- 欧州
• AIアタッチ率- 欧州
• GTM概要- 欧州

セクション4-ドイツ市場

• 市場概要-ドイツ
• マクロと疫学
• 医療制度と資金調達の情勢
• 規制とエビデンスパスウェイ
• 競合情勢
• 戦略的なポイントと推奨事項
• ドイツ市場、臨床分野別
• ドイツ市場、モダリティ別（2023年～2032年、100万米ドル）
• ドイツ市場、収益源別（2023年～2032年、100万米ドル）
• ドイツ市場、臨床応用別（2023年～2032年、100万米ドル）
• ドイツ市場、最終用途組織別（2023年～2032年、100万米ドル）
• ドイツ市場、AI技術別（2023年～2032年、100万米ドル）
• GTM概要- ドイツ

セクション5-フランス市場

• 市場サマリー：フランス
• フランス市場推計・予測（2023年～2032年）
• GTM概要- フランス

セクション6-英国市場

• 市場概要-英国
• 英国市場
• 英国市場推計・予測（2023年～2032年）
• GTM概要- 英国

セクション7-イタリア市場

• 市場概要とサマリー：イタリア
• イタリア市場予測（2023年～2032年）
• GTM概要- イタリア

セクション8-スペイン市場

• 市場概要とサマリー-スペイン
• 戦略的ポイント
• スペイン市場推計・予測（2023年～2032年）
• GTM概要- スペイン

第9章 -その他の欧州諸国市場

• 市場概要：その他の欧州諸国
• 戦略的ポイント
• 欧州の医用画像AI市場（2023年～2032年）
• GTM概要-その他の欧州諸国

List of Tables

• Table 1: AI Imaging Market by Country - Europe (2023-2032, USD Mill)
• Table 2: German Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 3: German Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 4: German Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 5: German Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 6: German Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 7: German Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 8: French Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 9: French Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 10: French Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 11: French Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 12: French Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 13: French Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 14: UK Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 15: UK Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 16: UK Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 17: UK Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 18: UK Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 19: UK Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 20: Italian Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 21: Italian Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 22: Italian Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 23: Italian Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 24: Italian Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 25: Italian Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 26: GTM Readiness Radar - Italy
• Table 27: Spanish Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 28: Spanish Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 29: Spanish Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 30: Spanish Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 31: Spanish Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 32: Spanish Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 33: Rest of Europe Market for AI in Medical Imaging by Clinical Area (2023-2032, USD Million)
• Table 34: Rest of Europe Market for AI in Medical Imaging by Modality (2023-2032, USD Million)
• Table 35: Rest of Europe Market for AI in Medical Imaging by Revenue Stream (2023-2032, USD Million)
• Table 36: Rest of Europe Market for AI in Medical Imaging by Clinical Application (2023-2032, USD Million)
• Table 37: Rest of Europe Market for AI in Medical Imaging by End-Use Organization (2023-2032, USD Million)
• Table 38: Rest of Europe Market for AI in Medical Imaging by AI Technology (2023-2032, USD Million)
• Table 39: Adjacency-Opportunity Matrix - ROE (2026-2030)
• Table 40: White-Space Partnership Matrix - ROE

List of Figures

• Figure 1: Top-Down Market Funnel - Europe
• Figure 2: Bottom-up Attach Rate Flow (Europe)
• Figure 3: Evidence Confidence (Europe Moel) - Density vs Reliability
• Figure 4: Regulatory Velocity by Company - Europe
• Figure 5: Markintel Growth Maturity Matrix - Europe
• Figure 6: Markintel(TM) Ecosystem Collaboration Matrix (ECM) - Europe
• Figure 7: Markintel Solution Adoption & Growth Matrix - Europe
• Figure 8: OEM AI Attach Rate - Europe (2024)
• Figure 9: AI Revenue Split - Factory vs Retrofit Attach -- Europe (2024)
• Figure 10: GTM Readiness Radar - Europe
• Figure 11: Potential by Customer Tier - Europe (2032)
• Figure 12: GTM Timeline (2025 -> 2028) - Europe
• Figure 13: Adjacency Opportunity Radar (2026+) - Europe
• Figure 14: Regulatory x Funding Heatmap - Europe (2024)
• Figure 15: AI Imaging Whitespace Matrix - Europe
• Figure 16: GTM Readiness Radar - Germany
• Figure 17: Projected Imaging AI Spend by Customer Tier - Germany (2032)
• Figure 18: GTM Timeline - Germany
• Figure 19: GTM Readiness Radar - What Counts Most in France
• Figure 20: GTM Timeline (2024-30) - France
• Figure 21: Spend Potential by Customer Tier - France (2032)
• Figure 22: GTM Readiness Radar - UK
• Figure 23: Spend Potential by Customer Tier - UK (2032)
• Figure 24: GTM Timeline (2024-29) - UK
• Figure 25: Tiered Customer Landscape & Spend Potential (2032)
• Figure 26: GTM Readiness Radar - Italy
• Figure 27: GTM Timeline (2024-29) - Italy
• Figure 28: GTM Readiness Radar - Spain
• Figure 29: Tiered Customer Landscape - Spain
• Figure 30: GTM Timeline - Spain (2024-2029)
• Figure 31: GTM at a Glance - Rest of Europe (ROE)
• Figure 32: Tiered Customer Landscape - ROE (2032)
• Figure 33: GTM Timeline - ROE
• Figure 34: Regulatory Funding Heatmap (ROE Clusters)

Report Metadata

• Geographic scope: Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Modalities: CT, MRI, X ray/DR, Ultrasound, PET/Nuclear
• Clinical areas: Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic
• Applications: Early detection/triage; diagnostic accuracy & classification; workflow/efficiency; prognosis & treatment; image enhancement/dose; segmentation/feature extraction; integration across modalities
• Revenue streams: Hardware (factory attach CAPEX uplift), Software (fixed licenses incl. enterprise subscriptions), Service (implementation/validation/support), Cloud/Pay per Use (metered per scan)
• End use: Hospitals, Imaging Centers, Clinics, Teleradiology, Other providers

Report Summary

The Europe - AI assisted Medical Imaging Pulse report sizes and forecasts AI spend across CT, MRI, X ray/DR, Ultrasound, and PET/Nuclear for DE, FR, UK, IT, ES, RoE. It provides 2023-24 actuals and a 2025-2032 forecasts by modality, clinical area, application, revenue stream, end use organization, and AI technology-plus GTM Growth & Maturity, Ecosystem Collaboration, and Solution Adoption & Growth frameworks tailored to Europe.

This 88 page Markintel(TM) Pulse report from Marketstrat(TM) delivers a Europe only view of AI in medical imaging. Regional frameworks-GTM Growth & Maturity (vendor view), Ecosystem Collaboration Matrix, and Solution Adoption & Growth-translate evidence into sequencing, partnering, and pricing decisions. Country chapters for Germany, France, the UK, Italy, Spain, and RoE include GTM readiness, pricing fit, and tiered customer landscapes. Methodology reconciles a top down Europe spend model with bottom up attach rate x ASP engines by modality and country, weighted by regulatory filings, audited financials, licensed expert transcripts, and RWE.

Country reality: Germany pivots to modular SaaS by 2027; UK favors cloud/usage pricing; France prioritizes integration & compliance; Italy grows MR led AI via PNRR; Spain's case is backlog reduction; RoE clusters show strong retrofit potential.

Decision ready frameworks: GTM Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth-all Europe level.

Who should use this report:

• OEM leadership (product, regional GMs, strategy)
• Specialist AI vendors & platforms (founders, sales leaders, partnerships)
• Provider networks (CIO/CMIO, radiology chairs, procurement)
• Investors & equity analysts (MedTech/HCIT)
• Consulting & advisory firms (GTM, pricing, diligence)

What decisions it supports (now/next quarter)

• Which solutions to bundle for enterprise/platform deals vs list in marketplaces.
• Pricing fit-term vs enterprise subscription vs usage based by country.
• Pilot to scale plans tied to procurement cadence and evidence expectations.
• Partner routes (OEM stores, PACS marketplaces, cloud exchanges) per country.

What's inside:

• Europe key numbers: totals and growth milestones through 2032.
• Breakdowns by modality, clinical area, application, revenue stream, end use, AI technology.
• Country chapters (DE, FR, UK, IT, ES, RoE) with: GTM readiness radar, country pricing matrix, tiered customer landscape, and forecast tables.
• Regional frameworks (Europe level):
  • GTM Growth & Maturity - vendor map
  • Ecosystem Collaboration Matrix (ECM)
  • Solution Adoption & Growth Matrix
• Methodology: dual lens model (top down reconciliation; bottom up attach rate x ASP), evidence weighting, QA checks.

Why buy this Pulse report:

• One coherent model: numbers reconcile across modality, country, application, and revenue stream.
• Evidence weighted: regulatory, financial and interview based signals are combined with clear confidence weights.
• Action oriented: frameworks translate data into sequencing, partnering, and pricing moves.
• Faster than a custom study: focused Europe scope you can use today.

Methods in brief:

• Dual lens architecture: top down Europe spend anchors totals; bottom up attach rate x ASP engines size each modality and country.
• Evidence pillars: CE MDR/UKCA filings, audited financials, licensed expert call transcripts, and peer reviewed or conference RWE.
• QA: numeric parity across tables/figures; documented source trail; second reader editorial check.

TABLE OF CONTENTS

SECTION 1 - EXECUTIVE SUMMARY

• What this Pulse Covers
• Key Numbers Snapshot (Europe)
• What's Driving Europe's Curve
• Where the Value Pools Form
• Country Outlook-Six Different Routes to Scale
• Near term Watchlist (Next 12-18 Months)
• What to do now (Insights -> Action)
  • OEMs
  • Pure plays
  • Providers & Networks
  • Investors

SECTION 2 - RESEARCH METHODOLOGY

• About this Pulse Report
• Scope & Segmentation
• Marketstrat's "Insights -> Action" Approach
• Dual lens Architecture
• Top down Market Funnel (Europe)
  • How it Works in the Model
• Bottom up Attach rate Flow (Europe)
• What we model for Each Country and Segment
• Evidence Confidence - Density vs Reliability (Europe)
  • Reading the Bubbles
• Regional Frameworks Included in this Pulse Report
• GTM Country Tools
• Quality Assurance & Governance
• Limitations & Mitigations

SECTION 3 - EUROPEAN MARKET ANALYSIS

• Market Overview & Analysis
  • Market Snapshot
  • Structural Demand Signals
  • Regulatory & Funding Landscape (2024-2028)
  • Market Segmentation 2032 (value share)
  • Competitive Heat Map (2024-26)
  • Execution Playbook (2024-2027)
  • Action-Oriented Recommendations
• European Market Estimates and Forecasts by Country (2023-2032, USD Mill)
  • Five Forces Shaping Adoption
  • Country Archetypes & What Sells
  • Near term Adoption Runway (2024-27)
  • Strategic Implications
  • Regulatory Velocity by Company - Europe
• Markintel Growth Maturity Matrix - Europe
  • Landscape Snapshot
  • Why the Quadrant Looks the Way it Does
  • Key Competitive Dynamics
  • Strategic Takeaways
  • Bottom Line
  • M&A Watchlist - Europe
  • Competitive Dataset - Europe
  • Growth & Maturity Highlights - Europe
• Markintel Ecosystem Collaboration Matrix (ECM) - Europe
  • Quadrant Commentary & European Illustrations
  • Action Checklist
• Markintel Solution Adoption & Growth Matrix - Europe
  • Quadrant Deep Dive
  • What Moves a Solution from One Box to the Next?
  • Strategic Guidance
• AI Attach Rate - Europe
  • OEM AI Attach Rate
  • Attach Rate Trends - Europe
  • AI Revenue Split - Factory vs Retrofit Attach -- Europe
• GTM at a Glance - Europe
  • Channel & Pricing Matrix (2025-2028)
  • GTM Readiness Radar - Europe
  • Tiered Customer Landscape (2032 View)
  • GTM Timeline (2025 -> 2028) - Europe
  • Adjacency Opportunity Radar (2026+) - Europe
  • Regulatory x Funding Heatmap - Europe
  • AI Imaging Whitespace Matrix - Europe
  • Fast Strategic Cues (2025 playbook)

SECTION 4 - GERMAN MARKET

• Market Overview - Germany
• Macro & Epidemiology
• Health system & Funding Landscape
• Regulatory & Evidence Pathway
• Competitive Landscape
• Strategic Takeaways & Recommendations
• German Market by Clinical Area
  • Forecast by Clinical Area (2023-2032, USD Mill)
  • Primary Growth Catalysts
  • Strategic Messages for Stakeholders
  • Key Takeaways
• German Market by Modality (2023-2032, USD Million)
  • Forecast by Modality (2023-2032, USD Mill)
  • Key Inflection by Modality
  • What's Driving Each Modality
  • Strategic Implications
• German Market by Revenue Stream (2023-2032, USD Million)
  • Forecast by Revenue Stream (2023-2032, USD Mill)
  • Revenue Streams and Drivers
  • Key Dynamics by Stream
  • Strategic Guidance
• German Market by Clinical Application (2023-2032, USD Million)
  • Forecast by Clinical Application (2023-2032, USD Mill)
  • What is Driving Each Bucket
  • Strategic Messages
  • Action Playbook
• German Market by End-Use Organization (2023-2032, USD Million)
  • Forecast by End-Use Organization (2023-2032, USD Mill)
  • Segments Review
  • Strategic Implications
• German Market by AI Technology (2023-2032, USD Million)
  • Forecast by AI Technology (2023-2032, USD Mill)
  • Germany - AI Imaging Market by Core Technology
  • Why Deep Learning Keeps the Lion's Share
  • Break-out Growth Themes
  • Strategic Playbook
• GTM at-a-Glance - Germany
  • Channel x Pricing Matrix
  • GTM Readiness Radar - Germany
  • Tiered Customer Landscape
  • GTM Timeline - Germany
  • Fast Strategic Cues

SECTION 5 - FRENCH MARKET

• Market Summary: France
  • Top line Snapshot - France
  • Key Market Dynamics
  • Strategic Takeaways
  • Top 3 Recommendations
  • French Market Speed scan - Market Analysis (2024-2032)
• French Market Estimates and Forecasts (2023-2032)
  • French Market by Clinical Area (2023-2032)
  • French Market by Modality (2023-2032)
  • French Market by Revenue Stream (2023-2032)
  • French Market by Clinical Application (2023-2032)
  • French Market by End-Use Organization (2023-2032)
  • French Market by AI Technology (2023-2032)
• GTM at a Glance - France
  • Channel x Pricing Matrix
  • GTM Readiness Radar - What Counts Most in France
  • GTM Timeline (2024-30) - France
  • Spend Potential by Customer Tier - France

SECTION 6 - UNITED KINGDOM MARKET

• Market Overview - United Kingdom
• UK Market Speed Scan
  • Scale & growth
  • Policy & funding
  • Demand triggers
  • Procurement routes
  • Competitive Field
  • Winning playbook 2024-27
• UK Market Estimates and Forecasts (2023-2032)
  • UK Market by Clinical Area (2023-2032)
  • UK Market by Modality (2023-2032)
  • UK Market by Revenue Stream (2023-2032)
  • UK Market by Clinical Application (2023-2032)
  • UK Market by End-Use Organization (2023-2032)
  • UK Market by AI Technology (2023-2032)
• GTM at a Glance - UK
  • Channel x Pricing Matrix
  • GTM Readiness Radar - UK
  • Fast Strategic Cues
  • Tiered Customer Landscape - UK
  • GTM Timeline (2024-29) - UK

SECTION 7 - ITALIAN MARKET

• Market Overview & Summary: Italy
  • What Makes Italy Unique in the EU Context
  • Strategic Takeaways
• Italian Market Estimates & Forecasts (2023-2032)
  • Italian Market by Clinical Area (2023-2032)
  • Italian by Modality (2023-2032)
  • Italian Market by Revenue Stream (2023-2032)
  • Italian Market by Clinical Application (2023-2032)
  • Italian Market by End-Use Organization (2023-2032)
  • Italian Market by AI Technology (2023-2032)
• GTM at a Glance - Italy
  • Channel x Pricing Matrix
  • Tiered Customer Landscape & Spend Potential (2032) - Italy
  • GTM Readiness Radar - Italy
  • GTM Timeline (2024-29) - Italy
  • Fast Strategic Cues

SECTION 8 - SPANISH MARKET

• Market Overview & Summary - Spain
• Strategic Takeaways
• Spanish Market Estimates and Forecasts (2023-2032)
  • Spanish Market by Clinical Area (2023-2032)
  • Spanish Market by Modality (2023-2032)
  • Spanish Market by Clinical Application (2023-2032)
  • Spanish Market by Revenue Stream (2023-2032)
  • Spanish Market by End-Use Organization (2023-2032)
  • Spanish Market by AI Technology (2023-2032)
• GTM at a Glance - Spain
  • GTM Readiness Radar - Spain
  • Channel x Pricing Matrix
  • Tiered Customer Landscape - Spain
  • GTM Timeline - Spain

SECTION 9 -REST OF EUROPE (ROE) MARKET

• Market Overview: Rest of Europe (ROE)
  • Size & trajectory
  • Why Growth Accelerates
  • Risks / Headwinds
• Strategic Takeaways
• Rest of European Market for AI in Medical Imaging (2023-2032)
  • Rest of European Market by Clinical Area (2023-2032)
  • Rest of European Market by Modality (2023-2032)
  • Rest of European Market by Revenue Stream (2023-2032)
  • Rest of European Market by Clinical Application (2023-2032)
  • Rest of European Market by End-Use Organization (2023-2032)
  • Rest of European Market by AI Technology (2023-2032)
• GTM at a Glance - Rest of Europe (ROE)
  • GTM Readiness Radar - ROE
  • Tiered Customer Landscape - ROE
  • GTM Timeline - ROE
  • Channel x Pricing Matrix
  • Adjacency-Opportunity Matrix (2026-2030)
  • Country-Cluster Framework & Strategic Playbook
  • White-Space Partnership Matrix
  • Regulatory Funding Heatmap (ROE Clusters)
  • Fast Strategic Cues